Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986
Self-citationHuebner, R. E., Schein, M. F., & Bass, J. B. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.6.968 · Cited by 917
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundGamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K., et al. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-13 · Cited by 886 · cited 6×
“While the number needed to treat based on IGRAs is not known with certainty, early evidence suggests that it is not likely to be dramatically different [24, 55].”
BackgroundInfluentialSelf-citationEdlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundYee, D., Valiquette, C., Pelletier, M., Parisien, I., Rocher, I., & Menzies, D. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-626oc · Cited by 840
Marais, B. J., Gie, R. P., Schaaf, H. S., Hesseling, A. C., Obihara, C. C., Starke, J., Enarson, D. A., Donald, P. R., & Beyers, N. (2004) · PubMed · Cited by 806
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
Steingart, K. R., Henry, M., Ng, V., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70578-3 · Cited by 798 · cited 1×
“Concentrated specimens have a mean increase in sensitivity of 18% compared with nonconcentrated specimens (using culture as the standard) and fluorescence microscopy is on average 10% more sensitive than conventional microscopy [128, 129].”
BackgroundSelf-citationWhole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak
Gardy, J. L., Johnston, J. C., Sui, S. J. H., Cook, V. J., Shah, L., Brodkin, E., Rempel, S., Moore, R., Zhao, Y., Holt, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003176 · Cited by 712 · cited 1×
“to investigation of tuberculosis outbreaks [240].”
THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE
COMSTOCK, G. W., LIVESAY, V. T., & WOOLPERT, S. F. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121593 · Cited by 698 · cited 1×
“Young children are at increased risk of developing TB following infection and more likely to develop severe disease than older children and adults [99, 100].”
BackgroundA systematic review of rapid diagnostic tests for the detection of tuberculosis infection
Dinnes, J., Deeks, J., Kunst, H., Gibson, A., Cummins, E., Waugh, N., Drobniewski, F., & Lalvani, A. (2007) · Health Technology Assessment · doi:10.3310/hta11030 · Cited by 666 · cited 1×
“The third meta-analysis stratified the NAAT test characteristics in AFB smear microscopy–negative suspects according to clinical suspicion of tuberculosis [137].”
MethodCarmona, L., Gómez‐Reino, J. J., Rodríguez‐Valverde, V., Montero, D., Pascual‐Gómez, E., Mola, E. M., Carreño, L., Figueroa, M., & BIOBADASER Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21043 · Cited by 656 · cited 1×
“to reduce the incidence of TB disease include household contacts of active TB patients [55, 63], native Alaskan communities [64], residents of mental health facilities [65], persons with HIV infection [66–69], and individuals treated with TNF inhibitors [70, 71].”
BackgroundPriorities for the Treatment of Latent Tuberculosis Infection in the United States
Horsburgh, C. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmsa031667 · Cited by 644 · cited 2×
“TB disease, with approximately half of these cases occurring following recent exposure [11, 17].”
BackgroundSchünemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-197st · Cited by 577
Steingart, K. R., Ng, V., Henry, M., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70602-8 · Cited by 573 · cited 1×
“Concentrated specimens have a mean increase in sensitivity of 18% compared with nonconcentrated specimens (using culture as the standard) and fluorescence microscopy is on average 10% more sensitive than conventional microscopy [128, 129].”
BackgroundSelf-citationBurr, J., Mowatt, G., Hernández, R., Siddiqui, M., Cook, J., Lourenco, T., Ramsay, C., Vale, L., Fraser, C., Azuara-Blanco, A., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11410 · Cited by 549
Iuat (1982) · Bulletin of the World Health Organization · Cited by 515
Ferrara, G., Losi, M., D'Amico, R., Roversi, P., Piro, R., Meacci, M., Meccugni, B., Dori, I. M., Andreani, A., Bergamini, B. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68579-6 · Cited by 505
Self-citationBerthet, F.-X., Rasmussen, P. B., Rosenkrands, I., Andersen, P., & Gicquel, B. (1998) · Microbiology · doi:10.1099/00221287-144-11-3195 · Cited by 486
(2000) · PubMed · Cited by 486
Harboe, M., Oettinger, T., Wiker, H. G., Rosenkrands, I., & Andersen, P. (1996) · Infection and Immunity · doi:10.1128/iai.64.1.16-22.1996 · Cited by 465 · cited 1×
“bovis (BCG strains) and most nontuberculous mycobacteria with the important exceptions of Mycobacterium kansasii, Mycobacterium szulgai, Mycobacterium marinum [32, 38], and Mycobacterium leprae [39, 40].”
BackgroundEffect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
Pape, J. W., Jean, S. S., Ho, J. L., Hafner, A., & Johnson, W. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)91817-6 · Cited by 441
Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus
Berenguer, J., Moreno, S., Laguna, F., Vicente, T., Adrados, M., Ortega, A., González-LaHoz, J., & Bouza, E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261004 · Cited by 432
The Host Immune Response to Tuberculosis
SCHLUGER, N. W., & ROM, W. N. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9708002 · Cited by 428 · cited 1×
“Whether or not inhaled tubercle bacilli establish an infection depends on both host and microbial factors [14].”
BackgroundWhalen, C. C., Johnson, J. L., Okwera, A., Hom, D. L., Huebner, R., Mugyenyi, P., Mugerwa, R. D., Ellner, J. J., Nsubuga, P., Vjecha, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371201 · Cited by 396
Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals.
Álvarez, S., & McCabe, W. R. (1984) · PubMed · Cited by 387
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
Martinson, N. A., Barnes, G. L., Moulton, L. H., Msandiwa, R., Hausler, H., Ram, M., McIntyre, J. A., Gray, G. E., & Chaisson, R. E. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005136 · Cited by 385
Pai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384 · cited 1×
“Meta-analyses have been published for the use of NAAT in suspected pleural and meningeal tuberculosis [224, 225].”
BackgroundSelf-citationNolan, C. M., Goldberg, S. V., & Buskin, S. E. (1999) · JAMA · doi:10.1001/jama.281.11.1014 · Cited by 368
Liebeschuetz, S., Bamber, S., Ewer, K., Deeks, J., Pathan, A. A., & Lalvani, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17592-2 · Cited by 367 · cited 1×
“As examples of the inconsistencies, a study using an IGRA similar to a currently available IGRA test demonstrated increased sensitivity of the IGRA compared with TST in children aged <3 years, especially among those coinfected with HIV and/or malnourished [121].”
ResultDiagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis
Liang, Q.-L., Shi, H.-Z., Wang, K., Qin, S.-M., & Qin, X.-J. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.12.007 · Cited by 356
Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.
Andersen, P., Andersen, A. B., Sørensen, A. L., & Nagai, S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3359 · Cited by 351
Extrapulmonary Tuberculosis Revisited: A Review of Experience at Boston City and Other Hospitals
ALVAREZ, S., & McCABE, W. R. (1984) · Medicine · doi:10.1097/00005792-198401000-00003 · Cited by 350
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Longini, I. M., Dye, C., & Halloran, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901720106 · Cited by 348 · cited 1×
“As described by Abu-Raddad et al [241], improved detection of those with TB and improved identification of those at risk to progress once infected have the potential to substantially decrease the prevalence of TB and its associated mortality.”
MethodAn Update on the Diagnosis of Tuberculosis Infection
Richeldi, L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1516pp · Cited by 346 · cited 1×
“Initial studies found that repeat TST testing did not alter the IGRA response [53, 54].”
ResultSelf-citationLalvani, A., Nagvenkar, P., Udwadia, Z., Pathan, A. A., Wilkinson, K. A., Shastri, J. S., Ewer, K., Hill, A. V. S., Mehta, A., & Rodrigues, C. (2001) · The Journal of Infectious Diseases · doi:10.1086/318081 · Cited by 343 · cited 1×
“” These spots are then enumerated as “footprints” [44] of effector T cells [44, 45].”
BackgroundChildhood Pulmonary Tuberculosis: Old Wisdom and New Challenges
Marais, B. J., Gie, R. P., Schaaf, H. S., Beyers, N., Donald, P. R., & Starke, J. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1809so · Cited by 342
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Ling, D. I., Zwerling, A. A., & Pai, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00061808 · Cited by 340 · cited 2×
“We evaluated systematic reviews with meta-analyses of 2 line probe assays [144, 145].”
BackgroundMethodSelf-citationTreatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis
Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., & Iseman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1159oc · Cited by 336 · cited 1×
“Drug susceptibility testing is essential because treatment success for patients with MDR-TB (can reach 75% or higher [150, 151]) is dependent upon patients being treated with an effective antimicrobial regimen [152].”
BackgroundSeibert, A. F., Haynes, J., Middleton, R., & Bass, J. B. (1991) · Chest · doi:10.1378/chest.99.4.883 · Cited by 320
Diagnosis and treatment of tuberculosis in children
Shingadia, D., & Novelli, V. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00771-0 · Cited by 302 · cited 1×
“A diagnosis of pulmonary tuberculosis can be made in the absence of laboratory confirmation, especially in children [139].”
BackgroundCattamanchi, A., Smith, R., Steingart, K. R., Metcalfe, J. Z., Date, A., Coleman, C., Marston, B. J., Huang, L., Hopewell, P. C., & Pai, M. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31820b07ab · Cited by 297 · cited 14×
“Currently, there are 2 commercially available IGRA platforms that measure interferon-γ release in response to Mtb-specific antigens: the QuantiFERON TB Gold In Tube (QFT-GIT; Cellestis Limited, Carnegie, Victoria, Australia) and T-SPOT.”
BackgroundInfluentialSelf-citationCruciani, M., Scarparo, C., Malena, M., Bosco, O., Serpelloni, G., & Mengoli, C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2321-2325.2004 · Cited by 291 · cited 1×
“8 days for the solid culture method) [132].”
BackgroundBerger, H. W., & Mejia, E. (1973) · Chest · doi:10.1378/chest.63.1.88 · Cited by 291
Detjen, A. K., Keil, T., Roll, S., Hauer, B., Mauch, H., Wahn, U., & Magdorf, K. (2007) · Clinical Infectious Diseases · doi:10.1086/519266 · Cited by 288 · cited 2×
“The study found that IGRAs were more specific than TST in children with nontuberculous mycobacterial disease [102].”
BackgroundResultMiliary tuberculosis: Rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults
Maartens, G., Willcox, P. A., & Benatar, S. R. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90340-j · Cited by 281 · cited 1×
“The large mortality reduction in this study would probably have been less dramatic if patients with tuberculous meningitis had been included, as 2 case series that included patients with tuberculous meningitis found that mortality due to disseminated tuberculosis is 20% [193, 194].”
BackgroundSerial Testing of Health Care Workers for Tuberculosis Using Interferon-γ Assay
Pai, M., Joshi, R., Dogra, S., Mendiratta, D. K., Narang, P., Kalantri, S., Reingold, A. L., Colford, J. M., Riley, L. W., & Menzies, D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-472oc · Cited by 275
Self-citationUpdated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
(2009) · JAMA · doi:10.1001/jama.2009.148 · Cited by 268
Epstein, D. M., Kline, L. R., Albelda, S. M., & Miller, W. T. (1987) · Chest · doi:10.1378/chest.91.1.106 · Cited by 266
Outcomes of Contact Investigations of Infectious Tuberculosis Patients
MARKS, S. M., TAYLOR, Z., QUALLS, N. L., SHRESTHA-KUWAHARA, R. J., WILCE, M. A., & NGUYEN, C. H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2004022 · Cited by 260 · cited 1×
“In some reports, only 17%–37% of those eligible for LTBI therapy ultimately complete the treatment course, with higher rates of completion associated with shorter courses of therapy [20, 21].”
BackgroundComparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Lee, J. Y., Choi, H. J., Park, I.-N., Hong, S.-B., Oh, Y.-M., Lim, C.-M., Lee, S. D., Koh, Y., Kim, W. S., Kim, D. S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00016906 · Cited by 257
Ferrara, G., Losi, M., Meacci, M., Meccugni, B., Piro, R., Roversi, P., Bergamini, B. M., D'Amico, R., Marchegiano, P., Rumpianesi, F., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-196oc · Cited by 250
Self-citationDelayed tuberculosis diagnosis and tuberculosis transmission.
Golub, J. E., Bur, S., Cronin, W. A., Gange, S. J., Baruch, N., Comstock, G. W., & Chaisson, R. E. (2006) · PubMed · Cited by 246
Singh, M. M., Bhargava, A. N., & Jain, K. P. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911132812003 · Cited by 246
Pai, M., Flores, L. L., Hubbard, A., Riley, L. W., & Colford, J. M. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-6 · Cited by 244 · cited 1×
“Meta-analyses have been published for the use of NAAT in suspected pleural and meningeal tuberculosis [224, 225].”
Self-citationMorgan, M., Kalantri, S., Flores, L., & Pai, M. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-62 · Cited by 243
Self-citation(1982) · Europe PMC (PubMed Central) · Cited by 236
Riquelme, A., Calvo, M., Salech, F., Valderrama, S., Pattillo, A., Arellano, M., Arrese, M., Soza, A., Viviani, P., & Letelier, L. M. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00009 · Cited by 233 · cited 1×
“level in peritoneal fluid are 100% and 97%, respectively [204].”
BackgroundWeiner, M., Benator, D., Burman, W., Peloquin, C. A., Khan, A., Vernon, A., Jones, B., Silva-Trigo, C., Zhao, Z., Hodge, T., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429321 · Cited by 226
Mase, S., Ramsay, A., Ng, V., Henry, M., Hopewell, P. C., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2007) · PubMed · Cited by 224
Self-citationUse of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic
LoBue, P. A., & Moser, K. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-390oc · Cited by 224
Self-citationLing, D. I., Flores, L. L., Riley, L. W., & Pai, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001536 · Cited by 222 · cited 1×
“The second meta-analysis reported an overall sensitivity of 85% and specificity of 97% and did not stratify according to the results of AFB smear microscopy [136].”
ResultSelf-citationSimon, H. B., Weinstein, A. J., Pasternak, M. S., Swartz, M. N., & Kunz, L. J. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90279-0 · Cited by 219
GENITOURINARY TUBERCULOSIS: REVIEW OF 102 CASES
CHRISTENSEN, W. I. (1974) · Medicine · doi:10.1097/00005792-197409000-00004 · Cited by 216
Evaluation of Investigations Conducted to Detect and Prevent Transmission of Tuberculosis
Reichler, M. R. (2002) · JAMA · doi:10.1001/jama.287.8.991 · Cited by 214 · cited 1×
“Those who are household contacts and are exposed to patients who are smear positive have higher rates of both infection and disease [12].”
BackgroundGreco, S., Girardi, E., Masciangelo, R., Capoccetta, G., & Saltini, C. (2003) · PubMed · Cited by 213
A controlled trial of community-wide isoniazid prophylaxis in Alaska.
Comstock, G. W., Ferebee, S. H., & Hammes, L. M. (1967) · PubMed · doi:10.1164/arrd.1967.95.6.935 · Cited by 211 · cited 1×
“to reduce the incidence of TB disease include household contacts of active TB patients [55, 63], native Alaskan communities [64], residents of mental health facilities [65], persons with HIV infection [66–69], and individuals treated with TNF inhibitors [70, 71].”
BackgroundOelemann, M. C., Diel, R., Vatin, V., Haas, W., Rüsch-Gerdes, S., Locht, C., Niemann, S., & Supply, P. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01393-06 · Cited by 211 · cited 1×
“The PCR-based methods are mycobacterial interspersed repetitive units (MIRU) and spacer oligonucleotide typing (spoligotyping) [232, 233].”
MethodBennett, D. E., Courval, J. M., Onorato, I., Agerton, T., Gibson, J. D., Lambert, L., McQuillan, G. M., Lewis, B., Navin, T. R., & Castro, K. G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-057oc · Cited by 209 · cited 1×
“An estimated 11 million persons are infected with Mtb [8].”
BackgroundEnding neglect: the elimination of tuberculosis in the United States
(2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00416-0 · Cited by 208
Meier, T., Eulenbruch, H.-P., Wrighton-Smith, P., Enders, G., & Regnath, T. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1377-8 · Cited by 205
Dorman, S. E., Belknap, R., Graviss, E. A., Reves, R., Schluger, N., Weinfurter, P., Wang, Y., Cronin, W., Hirsch-Moverman, Y., Teeter, L. D., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0365oc · Cited by 204
Self-citationDelayed type hypersensitivity: Current theories with a historic perspective
Black, C. A. (1999) · Dermatology Online Journal · doi:10.5070/d32fw0g1xx · Cited by 202
Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons
Markowitz, N., Hansen, N. I., Wilcosky, T. C., Hopewell, P. C., Glassroth, J., Kvale, P. A., Mangura, B. T., Osmond, D., Wallace, J. M., Rosen, M. J., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-3-199308010-00002 · Cited by 201 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Backgroundvan Zyl-Smit, R. N., Zwerling, A., Dheda, K., & Pai, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008517 · Cited by 201 · cited 4×
“However, more recent evidence [50, 51] suggests that the prior placement of a TST can boost an IGRA, particularly in those individuals who were already IGRA positive to begin with (ie, previously sensitized to Mtb or possibly other mycobacteria).”
BackgroundInfluentialSelf-citationConnell, T. G. (2006) · Thorax · doi:10.1136/thx.2005.048033 · Cited by 199
A Three-Way Comparison of Tuberculin Skin Testing, QuantiFERON-TB Gold and T-SPOT.TB in Children
Connell, T. G., Ritz, N., Paxton, G. A., Buttery, J. P., Curtis, N., & Ranganathan, S. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002624 · Cited by 198
Miliary Tuberculosis: Epidemiology, Clinical Manifestations, Diagnosis, and Outcome
Kim, J. H., Langston, A. A., & Gallis, H. A. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.4.583 · Cited by 197 · cited 1×
“The large mortality reduction in this study would probably have been less dramatic if patients with tuberculous meningitis had been included, as 2 case series that included patients with tuberculous meningitis found that mortality due to disseminated tuberculosis is 20% [193, 194].”
BackgroundDiagnostic Value of Interferon-γ in Tuberculous Pleurisy
Jiang, J., Shi, H.-Z., Liang, Q.-L., Qin, S.-M., & Qin, X.-J. (2007) · Chest · doi:10.1378/chest.06-2273 · Cited by 194
Delay in Diagnosis among Hospitalized Patients with Active Tuberculosis—Predictors and Outcomes
Greenaway, C., Menzies, D., Fanning, A., Grewal, R., Yuan, L., Mark FitzGerald, J., & The Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2107040 · Cited by 192
Immune Mechanisms in the Pathogenesis of Pulmonary Tuberculosis
Dannenberg, A. M. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_2.s369 · Cited by 191 · cited 1×
“tuberculosis infections are clinically and radiographically unapparent [16].”
BackgroundTest Variability of the QuantiFERON-TB Gold In-Tube Assay in Clinical Practice
Metcalfe, J. Z., Cattamanchi, A., McCulloch, C. E., Lew, J. D., Ha, N. P., & Graviss, E. A. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0430oc · Cited by 191 · cited 1×
“While the variations were quantitatively modest, results at or near the cutoff resulted in differing test results [52].”
ResultTreatment of latent tuberculosis infection: An update
LOBUE, P., & MENZIES, D. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01751.x · Cited by 190
Self-citationABADCO, D. L., & STEINER, P. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199209000-00013 · Cited by 190 · cited 1×
“dren with pulmonary TB has a yield of 10%–22% [167].”
Backgroundvan Zyl-Smit, R. N., Pai, M., Peprah, K., Meldau, R., Kieck, J., Juritz, J., Badri, M., Zumla, A., Sechi, L. A., Bateman, E. D., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1704oc · Cited by 188 · cited 4×
“However, more recent evidence [50, 51] suggests that the prior placement of a TST can boost an IGRA, particularly in those individuals who were already IGRA positive to begin with (ie, previously sensitized to Mtb or possibly other mycobacteria).”
BackgroundInfluentialSelf-citationFerebee, S. H., & MOUNT, F. W. (1962) · PubMed · doi:10.1164/arrd.1962.85.4.490 · Cited by 187 · cited 1×
“to reduce the incidence of TB disease include household contacts of active TB patients [55, 63], native Alaskan communities [64], residents of mental health facilities [65], persons with HIV infection [66–69], and individuals treated with TNF inhibitors [70, 71].”
BackgroundInitial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis
Lew, W., Pai, M., Oxlade, O., Martin, D., & Menzies, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00008 · Cited by 187 · cited 1×
“Drug susceptibility testing is essential because treatment success for patients with MDR-TB (can reach 75% or higher [150, 151]) is dependent upon patients being treated with an effective antimicrobial regimen [152].”
BackgroundSelf-citationEvaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Ruhwald, M., Bodmer, T., Maier, C., Jepsen, M., Haaland, M. B., Eugen-Olsen, J., & Ravn, P. (2008) · European Respiratory Journal · doi:10.1183/09031936.00055508 · Cited by 184
Flores, L. L., Pai, M., Colford, J. M., & Riley, L. W. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-55 · Cited by 181 · cited 1×
“The data on in-house tests show even greater heterogeneity [143].”
BackgroundSelf-citationHirsch‐Moverman, Y., Daftary, A., Franks, J. C., & Colson, P. W. (2008) · PubMed · Cited by 178
Catanzaro, A. (1982) · American Review of Respiratory Disease · doi:10.1164/arrd.1982.125.5.559 · Cited by 177
Pathogenesis of tuberculosis: pathway to apical localization
Balasubramanian, V., Wiegeshaus, E. H., Taylor, B. T., & Smith, D. W. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90002-7 · Cited by 177 · cited 1×
“the hilar lymph nodes and then through the bloodstream to more distant anatomic sites [15].”
BackgroundDogra, S., Narang, P., Mendiratta, D. K., Chaturvedi, P., Reingold, A. L., Colford, J. M., Riley, L. W., & Pai, M. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.04.007 · Cited by 172
Self-citationKampmann, B., Whittaker, E., Williams, A., Walters, S., Gordon, A., Martinez-Alier, N., Williams, B., Crook, A. M., Hutton, A.-M., & Anderson, S. T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00153408 · Cited by 164
Greco, S., Girardi, E., Navarra, A., & Saltini, C. (2006) · Thorax · doi:10.1136/thx.2005.054908 · Cited by 162 · cited 1×
“The first stratified the performance characteristics of NAAT based upon AFB smear results [135].”
BackgroundUse of Light‐Emitting Diode Fluorescence Microscopy to Detect Acid‐Fast Bacilli in Sputum
Marais, B. J., Brittle, W., Painczyk, K., Hesseling, A. C., Beyers, N., Wasserman, E., van Soolingen, D., & Warren, R. M. (2008) · Clinical Infectious Diseases · doi:10.1086/589248 · Cited by 161 · cited 1×
“Alternative methods for rapid molecular DST are being developed and other technologies are likely to become available in the near future (eg, automated real-time PCR with sequencing, LAMP) [162].”
MethodTrends in Drug-Resistant Tuberculosis in the United States, 1993-1996
Moore, M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550100059039 · Cited by 159
Improved Diagnostic Evaluation of Suspected Tuberculosis
Dosanjh, D. P. S., Hinks, T. S. C., Innes, J. A., Deeks, J. J., Pasvol, G., Hackforth, S., Varia, H., Millington, K. A., Gunatheesan, R., Guyot-Revol, V., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00003 · Cited by 159
CONDE, M. B., SOARES, S. L. M., MELLO, F. C. Q., REZENDE, V. M., ALMEIDA, L. L., REINGOLD, A. L., DALEY, C. L., & KRITSKI, A. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003125 · Cited by 159
Self-citationRapid Diagnosis of Smear-Negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot
Jafari, C., Ernst, M., Kalsdorf, B., Greinert, U., Diel, R., Kirsten, D. K., Marienfeld, K., Lalvani, A., & Lange, C. G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-465oc · Cited by 156
Latent Tuberculosis Diagnosis in Children by Using the QuantiFERON-TB Gold In-Tube Test
Lighter, J., Rigaud, M., Eduardo, R., Peng, C.-H., & Pollack, H. J. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3618 · Cited by 156
Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. J., & Portaels, F. (2000) · PubMed · Cited by 152
Bergamini, B. M., Losi, M., Vaienti, F., D’Amico, R., Meccugni, B., Meacci, M., Giovanni, D. D., Rumpianesi, F., Fabbri, L. M., Balli, F., et al. (2009) · PEDIATRICS · doi:10.1542/peds.2008-1722 · Cited by 146
Self-citationDiagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis
Goto, M., Noguchi, Y., Koyama, H., Hira, K., Shimbo, T., & Fukui, T. (2003) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456303766477011 · Cited by 145
Risk for Tuberculosis among Children
Nakaoka, H., Lawson, L., Squire, S. B., Coulter, B., Ravn, P., Brock, I., Hart, C. A., & Cuevas, L. E. (2006) · Emerging infectious diseases · doi:10.3201/eid1209.051606 · Cited by 144 · cited 2×
“The sensitivity of the TST has been reported as equivalent or increased compared with IGRAs in children [56, 59, 76, 101–105, 120], with young age associated with decreased IGRA positivity [107].”
ResultInduced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis
McWilliams, T. (2002) · Thorax · doi:10.1136/thorax.57.12.1010 · Cited by 144 · cited 2×
“In the second study, induced sputum was about one-third the cost of flexible bronchoscopy, and the most cost-effective strategy was 3 induced sputa without bronchoscopy [174].”
BackgroundResultComparison of Sputum Induction With Fiber-Optic Bronchoscopy in the Diagnosis of Tuberculosis
Anderson, C., Inhaber, N., & Menzies, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.5.7582296 · Cited by 139 · cited 1×
“Two cost-analysis studies favored sputum induction over bronchoscopy [172, 174].”
ResultMolecular diagnostics in tuberculosis
Cheng, V. C., Yew, W. W., & Yuen, K. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0039-1 · Cited by 137 · cited 2×
“generally speaking, the sensitivity was usually <90%, while the specificity was >95% (Supplementary Table 15) [191, 226].”
BackgroundDomínguez, J., Manzano, J. R., de Souza-Galvão, M. L., Latorre, I., Milà, C., Blanco, S., Jiménez, M. A., Prat, C., Lacoma, A., Altet, N., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00364-07 · Cited by 137
Tuberculous enteritis and peritonitis. Report of 36 general hospital cases
Sherman, S. (1980) · Archives of Internal Medicine · doi:10.1001/archinte.140.4.506 · Cited by 132
Tuberculous Meningitis in an Urban Medical Center
Ogawa, S. K., Smith, M. A. M., Brennessel, D., & Lowy, F. D. (1987) · Medicine · doi:10.1097/00005792-198707000-00004 · Cited by 131
Wilkinson, D., Squire, S. B., & Garner, P. (1998) · BMJ · doi:10.1136/bmj.317.7159.625 · Cited by 130
Mustafa, Amoudy, Wiker, H. G., ABAL, Ravn, P., OFTUNG, & Andersen, P. L. (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00419.x · Cited by 129
Cowan, L. S., Diem, L. A., Monson, T. A., Wand, P. J., Temporado, D., Oemig, T. V., & Crawford, J. T. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.688-695.2005 · Cited by 126 · cited 2×
“A standardized protocol has been developed to permit comparison of genotypes from different laboratories [232].”
MethodBurman, W. J., & Reves, R. R. (2000) · Clinical Infectious Diseases · doi:10.1086/317504 · Cited by 125 · cited 1×
“Genotyping is useful in detecting false-positive results due to confirming laboratory cross-contamination [234, 235], investigating outbreaks of TB (both detecting unsuspected outbreaks and confirming suspected outbreaks) [236], evaluating contact investigations [237], and determining whether new episodes of TB are du…”
BackgroundGeluk, A., van Meijgaarden, K. E., Franken, K. L. M. C., Subronto, Y. W., Wieles, B., Arend, S. M., Sampaio, E. P., de Boer, T., Faber, W. R., Naafs, B., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.5.2544-2548.2002 · Cited by 124 · cited 1×
“bovis (BCG strains) and most nontuberculous mycobacteria with the important exceptions of Mycobacterium kansasii, Mycobacterium szulgai, Mycobacterium marinum [32, 38], and Mycobacterium leprae [39, 40].”
BackgroundDillon, D. C., Alderson, M. R., Day, C. H., Bement, T., Campos‐Neto, A., Skeiky, Y. A. W., Vedvick, T., Badaró, R. J. D. S., Reed, S. G., & Houghton, R. L. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3285-3290.2000 · Cited by 124
Adenosine deaminase and tuberculous meningitis—A systematic review with meta-analysis
Tuon, F. F., Higashino, H. R., Lopes, M. I. B. F., Litvoc, M. N., Atomiya, A. N., Antonângelo, L., & Leite, O. M. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903428158 · Cited by 124 · cited 2×
“Two meta-analyses estimated the sensitivity and specificity of an elevated ADA level in the cerebrospinal fluid [195, 196].”
BackgroundNicol, M. P., Davies, M., Wood, K. J., Hatherill, M., Workman, L., Hawkridge, A., Eley, B., Wilkinson, K. A., Wilkinson, R. J., Hanekom, W. A., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0611 · Cited by 124
Chee, C. B. E., Gan, S. H., KhinMar, K. W., Barkham, T., Koh, C.-K., Shen, L., & Wang, Y. T. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02403-07 · Cited by 122
Kang, Y. A., Lee, H. W., Hwang, S.-S., Um, S., Han, S. K., Shim, Y.-S., & Yim, J. (2007) · CHEST Journal · doi:10.1378/chest.06-2805 · Cited by 117
Shakil, A. O., Korula, J., Kanel, G. C., Murray, N., & Reynolds, T. B. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89456-9 · Cited by 116
Schünemann, H. J., Osborne, M. L., Moss, J., Manthous, C. A., Wagner, G. R., Sicilian, L., Ohar, J. A., McDermott, S., Lucas, L., & Jaeschke, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0126st · Cited by 115 · cited 1×
“Conflicts of interest were managed according to the policies and procedures agreed upon by the participating organizations [1].”
MethodBronchoscopy and transbronchial biopsy in evaluation of patients with suspected active tuberculosis
Wallace, J. M., Deutsch, A. L., Harrell, J. H., & Moser, K. Μ. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90826-3 · Cited by 115 · cited 1×
“Bronchoscopic brushings yield AFB smear–positive results in 9%–56% [180, 185].”
BackgroundZellweger, J.-P., Sotgiu, G., Block, M. S., Dore, S., Altet, N., Blunschi, R., Bogyi, M., Bothamley, G. H., Bothe, C., Codecasa, L. R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0232oc · Cited by 113 · cited 3×
“While the number needed to treat based on IGRAs is not known with certainty, early evidence suggests that it is not likely to be dramatically different [24, 55].”
BackgroundEnding Neglect: The Elimination of Tuberculosis in the United States
Petty, T. L. (2001) · JAMA · doi:10.1001/jama.286.2.232 · Cited by 109
Brown, M., Varia, H., Bassett, P., Davidson, R. N., Wall, R. A., & Pasvol, G. (2007) · Clinical Infectious Diseases · doi:10.1086/516782 · Cited by 106 · cited 1×
“Five of the 6 studies demonstrated a higher yield from induced sputum than bronchoscopy, with the remaining study [176] demonstrating a similar yield.”
ResultTalati, N. J., Seybold, U., Humphrey, B. J., Aina, A., Tapia, J., Weinfurter, P., Albalak, R., & Blumberg, H. M. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-15 · Cited by 104 · cited 3×
“Finally, several studies have reported an increased rate of indeterminate IGRA results in children <5 years of age [47, 56–60] and one study described an increased rate of indeterminate IGRA results among individuals with HIV infection and a CD4 count ≤200 cells/μL [61]”
BackgroundResultHarada, N., Higuchi, K., Yoshiyama, T., Kawabe, Y., Fujita, A., Sasaki, Y., Horiba, M., Mitarai, S., Yonemaru, M., Ogata, H., et al. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.02.011 · Cited by 103
Diagnosis of pulmonary tuberculosis by flexible fiberoptic bronchoscopy.
Danek, S. J., & Bower, J. S. (1979) · PubMed · doi:10.1164/arrd.1979.119.4.677 · Cited by 100 · cited 1×
“Postbronchoscopy AFB smears have a diagnostic yield of 9%–73% and postbronchoscopy mycobacterial cultures have a yield of 35%–71% according to multiple studies [182, 185, 187, 188].”
BackgroundFowler, N. O., & Manitsas, G. T. (1973) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(73)80004-0 · Cited by 99
Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis?
Hatherill, M., Hawkridge, T., Zar, H. J., Whitelaw, A. C., Tameris, M. D., Workman, L., Geiter, L. J., Hanekom, W. A., & Hussey, G. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.136929 · Cited by 97 · cited 1×
“Sputum collected from children by nasopharyngeal aspiration or sputum induction with a bronchodilator has a yield of 20%–30% [166], whereas gest on D ecem er 9, 2016 http://cidrdjournals.”
BackgroundGoletti, D., Carrara, S., Butera, O., Amicosante, M., Ernst, M., Sauzullo, I., Vullo, V., Cirillo, D. M., Borroni, E., Markova, R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003417 · Cited by 96
Adenosine deaminase and tuberculous pericarditis—A systematic review with meta-analysis
Tuon, F. F., Litvoc, M. N., & Lopes, M. I. B. F. (2006) · Acta Tropica · doi:10.1016/j.actatropica.2006.07.004 · Cited by 94 · cited 1×
“and specificity of an elevated ADA level in pericardial fluid are 88% and 83%, respectively [203].”
BackgroundMustafa, A. S., Oftung, F., Amoudy, H. A., Madi, N., Abal, A. T., Shaban, F. A., Krands, I. R., & Andersen, P. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313862 · Cited by 94
Diagnostic Yield of Sputum, Induced Sputum, and Bronchoscopy after Radiologic Tuberculosis Screening
Schoch, O. D., Rieder, P., Tueller, C., Altpeter, E., Zellweger, J.-P., Rieder, H. L., Krause, M., & Thurnheer, R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1092oc · Cited by 94 · cited 1×
“Postbronchoscopy AFB smears have a diagnostic yield of 9%–73% and postbronchoscopy mycobacterial cultures have a yield of 35%–71% according to multiple studies [182, 185, 187, 188].”
BackgroundZahrani, K. A. A., Jahdali, H. A., Poirier, L., René, P., & Menzies, D. (2001) · PubMed · Cited by 92
Clark, S. A., Martin, S. L., Pozniak, A., Steel, A., Ward, B., Dunning, J. W., Henderson, D. C., Nelson, M. R., Gazzard, B., & Kelleher, P. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03477.x · Cited by 91
A controlled trial of isoniazid prophylaxis in mental institutions
Ferebee, S. H., MOUNT, F. W., Murray, F. J., & Livesay, V. T. (1964) · Nursing Research · doi:10.1097/00006199-196401320-00046 · Cited by 91 · cited 1×
“to reduce the incidence of TB disease include household contacts of active TB patients [55, 63], native Alaskan communities [64], residents of mental health facilities [65], persons with HIV infection [66–69], and individuals treated with TNF inhibitors [70, 71].”
BackgroundMoore, D. F., Guzman, J. A., & Mikhail, L. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.014 · Cited by 83 · cited 1×
“men, some clinicians may find it beneficial in the diagnosis of individual patients [140, 141].”
BackgroundHighly discordant T cell responses in individuals with recent exposure to household tuberculosis
Hesseling, A. C., Mandalakas, A. M., Kirchner, H. L., Chegou, N. N., Marais, B. J., Stanley, K., Zhu, X., Black, G. F., Beyers, N., & Walzl, G. (2008) · Thorax · doi:10.1136/thx.2007.085340 · Cited by 81 · cited 2×
“are household [106, 107] or school [108] contacts and the specificity of IGRAs in children [102, 108] are comparable to those of adults.”
ResultEffect of tuberculin skin testing on aMycobacterium tuberculosis-specific interferon-γ assay
Leyten, E. M. S., Prins, C., Bossink, A. W. J., Thijsen, S. F. T., Ottenhoff, T. H. M., van Dissel, J. T., & Arend, S. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00117506 · Cited by 79
Use of the flexible fibreoptic bronchoscope in diagnosis of sputum-negative pulmonary tuberculosis.
Willcox, P. A., Benatar, S. R., & Potgieter, P. D. (1982) · Thorax · doi:10.1136/thx.37.8.598 · Cited by 79 · cited 1×
“It has been reported that bronchial washings, brushings, and TBB have diagnostic yields of 14% [234], 27%–78% [181, 189, 190], and 32%–75% [181, 189, 190], respectively.”
BackgroundXu, H.-B., Jiang, R.-H., Li, L., Sha, W., & Xiao, H.-P. (2010) · PubMed · Cited by 78
Clinical and Pathological Features of Tuberculous Pleural Effusion and Its Long-Term Consequences
Chan, C. H. S., Arnold, M., Chan, C. Y., Mak, T. W. L., & Hoheisel, G. (2009) · Respiration · doi:10.1159/000195921 · Cited by 78
Tsiouris, S., Austin, J., Toro, P. L., Coetzee, D. J., Weyer, K., STEIN, Z. A., & El-Sadr, W. M. (2006) · PubMed · Cited by 77
Kennedy, D. J., Lewis, W. P., & Barnes, P. F. (1992) · CHEST Journal · doi:10.1378/chest.102.4.1040 · Cited by 77 · cited 2×
“HIV-infected patients are less likely (9%–19%) to demonstrate granulomas on TBB [183, 186], although in 2 studies TBB was”
BackgroundInterferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis
Sun, L., Xiao, J., Miao, Q., Feng, W., Wu, X., Yin, Q.-Q., Jiao, W., Shen, C., Liu, F., Shen, D., et al. (2011) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00838.x · Cited by 77 · cited 1×
“The specificity of IGRAs appears to be excellent in children in the range of 90%–100% [122] according to a study conducted in children who had nontuberculous mycobacteria.”
BackgroundAvaliação da adenosina desaminase no diagnóstico da tuberculose pleural: uma metanálise brasileira
Morisson, P., & Neves, D. D. (2008) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132008000400006 · Cited by 77
Tuberculosis trends--United States, 2014.
Scott, C., Kirking, H. L., Jeffries, C. D., Price, S. F., & Pratt, R. H. (2015) · PubMed Central · Cited by 75
Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis
Charoenratanakul, S., Dejsomritrutai, W., & Chaiprasert, A. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90231-7 · Cited by 75 · cited 1×
“The diagnostic yield of induced sputum increases with multiple specimens, with detection rates by AFB smear microscopy of 91%–98% and mycobacterial culture of 99%–100% reported when 3 or more specimens are obtained [178].”
BackgroundMultidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
Granich, R. (2005) · JAMA · doi:10.1001/jama.293.22.2732 · Cited by 75
A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.
Ferebee, S. H., MOUNT, F. W., MURRAY, F. J., et al. (1963) · PubMed · doi:10.1164/arrd.1963.88.2.161 · Cited by 74
OKADA, K., Mao, T., Mori, T., Miura, T., SUGIYAMA, T., Yoshiyama, T., Mitarai, S., Onozaki, I., Harada, N., Saint, S. K., et al. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009831 · Cited by 72
Geluk, A., van Meijgaarden, K. E., Franken, K. L. M. C., Wieles, B., Arend, S. M., Faber, W. R., Naafs, B., & Ottenhoff, T. H. M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01358.x · Cited by 72 · cited 1×
“bovis (BCG strains) and most nontuberculous mycobacteria with the important exceptions of Mycobacterium kansasii, Mycobacterium szulgai, Mycobacterium marinum [32, 38], and Mycobacterium leprae [39, 40].”
BackgroundColangeli, R., Spencer, J. S., Bifani, P. J., Williams, A., Lyashchenko, K. P., Keen, M. A., Hill, P. J., Belisle, J. T., & Gennaro, M. L. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.990-993.2000 · Cited by 69
Sağlam, L., Akgün, M., & Aktas, E. (2005) · Journal of International Medical Research · doi:10.1177/147323000503300215 · Cited by 67
Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
Wang, J., Chou, C., Lee, L., Hsu, H., Jan, I., Hsueh, P., Yang, P., & Luh, K. (2007) · Emerging infectious diseases · doi:10.3201/eid1304.051195 · Cited by 66
Vincenti, D., Carrara, S., Butera, O., Bizzoni, F., Casetti, R., Girardi, E., & Goletti, D. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03462.x · Cited by 65
Use of QuantiFERON®‐TB Gold to investigate tuberculosis contacts in a high school
Higuchi, K., Harada, N., Mori, T., & Sekiya, Y. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.01000.x · Cited by 65 · cited 1×
“are household [106, 107] or school [108] contacts and the specificity of IGRAs in children [102, 108] are comparable to those of adults.”
ResultThe Spectrum of Tuberculous Peritonitis
Karney, W. W., O'Donoghue, J. M., Ostrow, J. H., Holmes, K. K., & Beaty, H. N. (1977) · CHEST Journal · doi:10.1378/chest.72.3.310 · Cited by 64
Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscope.
Willcox, P. A., Potgieter, P. D., Bateman, E. D., & Benatar, S. R. (1986) · Thorax · doi:10.1136/thx.41.9.681 · Cited by 64
The validity of acid-fast smears in the diagnosis of pulmonary tuberculosis.
Gordin, F. M., & Slutkin, G. (1990) · PubMed · Cited by 63
Gui, X., & Xiao, H. (2014) · PubMed Central · Cited by 63
Zhu, R.-Y., Zhang, K., Zhao, M., Liu, Y., Xu, Y.-Y., Ju, C., Li, B., & Chen, J. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2009.07.006 · Cited by 60 · cited 1×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundRadhakrishna, S., Frieden, T. R., & Subramani, R. (2003) · PubMed · Cited by 58
Chee, C. B. E., SOH, C. H., Boudville, I. C., CHOR, S. S., & WANG, Y. T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2101093 · Cited by 58 · cited 1×
“With respect to the TST, the result is categorized as positive or negative and quantitative data are of limited utility, with the exception of recognition that a large (>15 mm) skin test reaction is more likely to reflect infection with Mtb [109, 110].”
BackgroundTreatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994–1997
Narita, M., Alonso, P. L., Lauzardo, M., Hollender, E. S., Pitchenik, A. E., & Ashkin, D. (2001) · CHEST Journal · doi:10.1378/chest.120.2.343 · Cited by 58 · cited 1×
“Drug susceptibility testing is essential because treatment success for patients with MDR-TB (can reach 75% or higher [150, 151]) is dependent upon patients being treated with an effective antimicrobial regimen [152].”
BackgroundFibreoptic bronchoscopy in smear-negative pulmonary tuberculosis
Chawla, R., Pant, K., Jaggi, O., Chandrashekhar, S., & Thukral, S. (1988) · European Respiratory Journal · doi:10.1183/09031936.93.01090804 · Cited by 58 · cited 1×
“Bronchoscopic brushings yield AFB smear–positive results in 9%–56% [180, 185].”
BackgroundESAT‐6 and CFP‐10 in Clinical versus Environmental Isolates ofMycobacterium kansasii
Arend, S. M., de Haas, P., Leyten, E. M. S., Rosenkrands, I., Rigouts, L., Andersen, P. L., Mijs, W., van Dissel, J. T., & van Soolingen, D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428950 · Cited by 57 · cited 1×
“bovis (BCG strains) and most nontuberculous mycobacteria with the important exceptions of Mycobacterium kansasii, Mycobacterium szulgai, Mycobacterium marinum [32, 38], and Mycobacterium leprae [39, 40].”
BackgroundMalakmadze, N., González, I. M., Oemig, T. V., Isiadinso, I., Rembert, D., McCauley, M. M., Wand, P. J., Diem, L. A., Cowan, L., Palumbo, G. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427112 · Cited by 56 · cited 2×
“Genotyping is useful in detecting false-positive results due to confirming laboratory cross-contamination [234, 235], investigating outbreaks of TB (both detecting unsuspected outbreaks and confirming suspected outbreaks) [236], evaluating contact investigations [237], and determining whether new episodes of TB are du…”
BackgroundSalzman, S. H., Schindel, M. L., Aranda, C. P., Smith, R. L., & Lewis, M. L. (1992) · CHEST Journal · doi:10.1378/chest.102.1.143 · Cited by 56
&NA; (2002) · Journal of Bronchology · doi:10.1097/00128594-200204000-00029 · Cited by 56
Primary Drug-Resistant Tuberculosis in Children
Steiner, P. (1985) · American journal of diseases of children · doi:10.1001/archpedi.1985.02140100042023 · Cited by 54 · cited 1×
“While it is tempting to avoid culture collection from the child contact when a putative source case is identified (especially when susceptibility results are already available), prior case series indicate that 2%–10% of children have susceptibility patterns that differ from the presumed source case [168] and more rece…”
ResultYajko, D. M., NASSOS, P. S., Sanders, C. A., Madej, J. J., & HADLEY, W. K. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.2.334 · Cited by 52 · cited 1×
“The specificity of microscopy is relatively high (≥90%), but the positive predictive value (PPV) varies (70%–90%) depending upon the prevalence of tuberculosis versus nontuberculous mycobacterial disease [130, 131].”
BackgroundBothamley, G. H., & Rudd, R. M. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07020240 · Cited by 49
Millington, K. A., Gooding, S., Hinks, T., Reynolds, D. J., & Lalvani, A. (2010) · The Journal of Infectious Diseases · doi:10.1086/656772 · Cited by 49
Reichler, M. R., Reves, R. R., Bur, S., FORD, J., Thompson, V., Mangura, B. T., Onorato, I. M., & Valway, S. E. (2002) · Southern Medical Journal · doi:10.1097/00007611-200204000-00008 · Cited by 48
Early Detection of Perinatal Tuberculosis Using a Whole Blood Interferon- Release Assay
Connell, T. G., Zeev, N. B., & Curtis, N. C. (2006) · Clinical Infectious Diseases · doi:10.1086/503910 · Cited by 47
Park, S. Y., Jeon, K., Um, S., Kwon, O. J., Kang, E., & Koh, W. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903214298 · Cited by 45
Molecular Fingerprinting ofMycobacterium tuberculosis: How Can It Help the Clinician?
Behr, M. A., & Small, P. M. (1997) · Clinical Infectious Diseases · doi:10.1086/515550 · Cited by 45 · cited 1×
“Genotyping is useful in detecting false-positive results due to confirming laboratory cross-contamination [234, 235], investigating outbreaks of TB (both detecting unsuspected outbreaks and confirming suspected outbreaks) [236], evaluating contact investigations [237], and determining whether new episodes of TB are du…”
BackgroundUnderreading of the Tuberculin Skin Test Reaction
Kendig, E. L., Kirkpatrick, B. V., Carter, W. H., Hill, F. A., Caldwell, K., & Entwistle, M. (1998) · CHEST Journal · doi:10.1378/chest.113.5.1175 · Cited by 44 · cited 1×
“In this regard, the TST has well-known strengths and limitations [23, 25, 26].”
BackgroundTuberculous meningitis in an urban general hospital
Haas, E. J. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.11.1518 · Cited by 44
Management of Tuberculous Pericarditis
Quale, J. M., Lipschik, G. Y., & Heurich, A. E. (1987) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60243-3 · Cited by 41
Do results of the T-SPOT.TB interferon-γ release assay change after treatment of tuberculosis?
Bosshard, V., Roux‐Lombard, P., Perneger, T., Metzger, M., Vivien, R., Rochat, T., & Janssens, J.-P. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.012 · Cited by 41
Fiberoptic bronchoscopy in the diagnosis of pulmonary tuberculosis
Sarkar, S., Sharma, G. S., Gupta, P. R., & Sharma, R. (1980) · Tubercle · doi:10.1016/0041-3879(80)90017-3 · Cited by 38
Pai, M., & Ling, D. I. (2008) · Future Microbiology · doi:10.2217/17460913.3.1.1 · Cited by 37 · cited 1×
“generally speaking, the sensitivity was usually <90%, while the specificity was >95% (Supplementary Table 15) [191, 226].”
BackgroundSelf-citationMiro, A. M., Gibilara, E., Powell, S., & Kamholz, S. L. (1992) · CHEST Journal · doi:10.1378/chest.101.5.1211 · Cited by 37
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
“A cytokine release assay analogous to the tuberculosis IFNg release assay is a possibility (Lewinsohn et al., 2017; Murugesan et al., 2020; Petrone et al., 2020), as are plasmaCXCL10 (Rydyznski Moderbacher et al.”
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
“The figures for free IFN-λ were ≥89% and ≥97% for sensitivity and specificity, respectively [121].”
BackgroundMethodThe global prevalence of latent tuberculosis: A systematic review and meta-analysis
Cohen, A., Mathiasen, V. D., Schön, T., & Wejse, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00655-2019 · Cited by 547
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1874st · Cited by 462
“The WHO-recommended standardized shorter-course 9-to 11-month regimen for MDR-TB was estimated by the guidelines committee to have minimal desirable effects (on treatment success, mortality, culture conversions) and small to moderate undesirable effects (adverse events, the use of drugs for which there is documented o…”
InfluentialSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
“The figures for free IFN-λ were ≥89% and ≥97% for sensitivity and specificity, respectively [121].”
BackgroundMethod
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.